Tech Company Financing Transactions
GeneAssess Funding Round
On 7/3/2012, GeneAssess received $500 thousand in funding from Foundation Venture Capital Group.
Transaction Overview
Company Name
Announced On
7/3/2012
Transaction Type
Venture Equity
Amount
$500,000
Round
Undisclosed
Investors
Foundation Venture Capital Group (George Heinrich)
Proceeds Purpose
GeneAssess plans to use the investment to validate FRY as a predictive biomarker for breast and other cancers, to detect genetic mutations in at-risk populations and to explore target validation for FRY.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
New Brunswick, NJ 08901
USA
New Brunswick, NJ 08901
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
GeneAssess plans to validate FRY as a predictive biomarker for breast and other cancers, to detect genetic mutations in at-risk populations and to explore target validation for FRY.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Helmut Zarbl
Browse more venture capital transactions:
Prev: 7/3/2012: Narrative Science venture capital transaction
Next: 7/3/2012: ConnectYard venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs